Home
>
National Drug Code (NDC)
>
ALTABAX
ALTABAX - 0007-5180-22 - (retapamulin)
Drug Information of ALTABAX
| Product NDC: | 0007-5180 |
| Proprietary Name: | ALTABAX |
| Non Proprietary Name: | retapamulin |
| Active Ingredient(s): | 10 mg/g & nbsp; retapamulin |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ALTABAX
| Product NDC: | 0007-5180 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022055 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20070502 |
Package Information of ALTABAX
| Package NDC: | 0007-5180-22 |
| Package Description: | 15 g in 1 TUBE (0007-5180-22) |
NDC Information of ALTABAX
| NDC Code | 0007-5180-22 |
| Proprietary Name | ALTABAX |
| Package Description | 15 g in 1 TUBE (0007-5180-22) |
| Product NDC | 0007-5180 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | retapamulin |
| Dosage Form Name | OINTMENT |
| Route Name | TOPICAL |
| Start Marketing Date | 20070502 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | RETAPAMULIN |
| Strength Number | 10 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | pleuromutilin [Chemical/Ingredient],Pleuromutilin Antibacterial [EPC] |
